SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-041597
Filing Date
2023-02-17
Accepted
2023-02-17 08:52:13
Documents
7
Effectiveness Date
2023-02-17

Document Format Files

Seq Description Document Type Size
1 S-8 d265868ds8.htm S-8 35336
2 EX-5.1 d265868dex51.htm EX-5.1 8540
3 EX-23.2 d265868dex232.htm EX-23.2 1696
4 EX-99.4 d265868dex994.htm EX-99.4 2532
5 EX-FILING FEES d265868dexfilingfees.htm EX-FILING FEES 15172
6 GRAPHIC g265868dsp7.jpg GRAPHIC 7428
7 GRAPHIC g265868g0214104838149.jpg GRAPHIC 1649
  Complete submission text file 0001193125-23-041597.txt   77084
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269845 | Film No.: 23640429
SIC: 2834 Pharmaceutical Preparations